Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy
Status:
Terminated
Trial end date:
2020-11-04
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled Phase 2a Study Examining the Safety
and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy